✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Rekvina Laboratories Ltd.

REKVINA LAB.

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹10 Cr.
P/E
0.00

Rekvina Laboratories Ltd.

  • Rekvina Labs
  • Secunderabad Health.
  • Ortin Global

FAQs on Rekvina Laboratories Ltd. Shareprice

Rekvina Labs has given better returns compared to its competitors.
Rekvina Labs has grown at ~37.38% over the last 4yrs while peers have grown at a median rate of 3.5%

There is insufficient historical data to gauge this.
Latest PE of Rekvina Labs is 0

View FAQ's On Business

Growth Table

  • Rekvina Laboratories Ltd.
  • Secunderabad Health.
  • Ortin Global

Balance Sheet

  • Rekvina Laboratories Ltd.
  • Secunderabad Health.
  • Ortin Global

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Rekvina Laboratories Ltd.
  • Secunderabad Health.
  • Ortin Global

Cash Flow

  • Rekvina Laboratories Ltd.
  • Secunderabad Health.
  • Ortin Global

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Rekvina Laboratories Ltd.
  • Secunderabad Health.
  • Ortin Global

Quarterly Results

  • Rekvina Laboratories Ltd.
  • Secunderabad Health.
  • Ortin Global

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Rekvina Laboratories Ltd. Financials

Rekvina Labs balance sheet is weak and might have solvency issues

Yes, The net debt of Rekvina Labs is increasing.
Latest net debt of Rekvina Labs is ₹0.81 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹0.2 Crs.

No, profit is decreasing.
The profit of Rekvina Labs is -₹0.14 Crs for Mar 2025, -₹0.02 Crs for Mar 2024 and ₹0 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Rekvina Labs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech